AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Essential Site Maintenance
: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at
[email protected]
in case you face any issues.
Eloise Silvester
Public Documents
1
Switching antifungals drugs within the triazole drug class: a potential treatment app...
Eloise Silvester
and 2 more
January 12, 2023
There are limited data on the best approach to managing azole-induced hepatotoxicity. One described approach is switching between different triazole agents to prevent the need for intravenous therapy. This case series describes the outcomes of this approach in seven children. The most common azole switch was voriconazole to fluconazole (3/7), followed by fluconazole to voriconazole (2/7). One child each switched from voriconazole to itraconazole, and posaconazole to fluconazole. Of the seven cases, five had Grade 3 liver injury and two had Grade 2 liver injury. These LFT abnormalities were deemed as ‘possibly’ in four cases, and ‘probably’ in three cases to be related to the first azole antifungal as per the Naranjo criteria. All had improvement in their LFT abnormalities after the switch to an alternative azole antifungal. These data suggest that switching azole antifungals offers a potential treatment approach to azole-induced hepatotoxicity.